Total Funding
72
68
Total FundingPost-IPO Equity raised
Growth Score 72 in past quarter
-7 pts
Heat Score 68 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
68900
NetraMark is an AI and pharma-tech company, has developed proprietary solutions for pharmaceutical and biotechnology companies.
- Angelico Carta: Chief Strategy Officer
- Jan Sedway: Senior Vice President of Clinical SciencePast Role: Clario, Vice President of Clinical Development
About the Company
NetraMark is an AI and the pharma-tech company that has developed proprietary solutions for pharmaceutical and biotechnology companies. These solutions allow clients to leverage small to large data in order to optimize clinical trials and drug development. This is accomplished by providing a superior understanding of their patient populations and
these insights are also used to develop new drugs and nutraceuticals.